Patrik Brundin (Former)
1 – 248 of 248
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Decreased Risk of Parkinson's Disease After Rheumatoid Arthritis Diagnosis : A Nested Case-Control Study with Matched Cases and Controls
(
- Contribution to journal › Article
- 2020
-
Mark
GDNF and Parkinson's Disease : Where Next? A Summary from a Recent Workshop
(
- Contribution to journal › Article
- 2018
-
Mark
The vermiform appendix impacts the risk of developing Parkinson’s disease
(
- Contribution to journal › Article
- 2017
-
Mark
Exendin-4 treatment improves LPS-induced depressive-like behavior without affecting pro-inflammatory cytokines
(
- Contribution to journal › Article
- 2016
-
Mark
The CD44 ligand hyaluronic acid is elevated in the cerebrospinal fluid of suicide attempters and is associated with increased blood-brain barrier permeability.
(
- Contribution to journal › Article
-
Mark
Identification of multiple QTLs linked to neuropathology in the engrailed-1 heterozygous mouse model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation
(
- Contribution to journal › Article
-
Mark
Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016?
(
- Contribution to journal › Article
- 2015
-
Mark
A cell culture model for monitoring α-synuclein cell-to-cell transfer.
(
- Contribution to journal › Article
-
Mark
Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis.
(
- Contribution to journal › Scientific review
-
Mark
Acceleration of α-synuclein aggregation by exosomes
(
- Contribution to journal › Article
- 2014
-
Mark
Lesion of the subiculum reduces the spread of amyloid beta pathology to interconnected brain regions in a mouse model of Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Intracellular Nogo-A facilitates initiation of neurite formation in mouse midbrain neurons in vitro.
(
- Contribution to journal › Article
-
Mark
Adipocytes derived from PA6 cells reliably promote the differentiation of dopaminergic neurons from human embryonic stem cells.
(
- Contribution to journal › Article
-
Mark
Alpha-synuclein transfers from neurons to oligodendrocytes.
(
- Contribution to journal › Article
-
Mark
Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Is Exenatide the Next Big Thing in Parkinson's Disease?
(
- Contribution to journal › Article
-
Mark
Review: The future of cell therapies and brain repair: Parkinson's disease leads the way.
(
- Contribution to journal › Scientific review
-
Mark
Long-term clinical outcome of fetal cell transplantation for Parkinson disease : two case reports
(
- Contribution to journal › Article
-
Mark
The role of Galectin-3 in α-synuclein-induced microglial activation
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Microchannel Acoustophoresis does not Impact Survival or Function of Microglia, Leukocytes or Tumor Cells.
(
- Contribution to journal › Article
-
Mark
Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
A new approach to disease-modifying drug trials in Parkinson's disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Mind the gut: secretion of alpha-synuclein by enteric neurons
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Nonsteroidal Selective Androgen Receptor Modulators and Selective Estrogen Receptor β Agonists Moderate Cognitive Deficits and Amyloid-β Levels in a Mouse Model of Alzheimer's Disease.
(
- Contribution to journal › Article
-
Mark
Adsorption of α-Synuclein to Supported Lipid Bilayers: Positioning and Role of Electrostatics.
(
- Contribution to journal › Article
-
Mark
α-Synuclein: The Long Distance Runner.
(
- Contribution to journal › Article
-
Mark
What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
(
- Contribution to journal › Article
-
Mark
Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice.
(
- Contribution to journal › Article
-
Mark
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
(
- Contribution to journal › Scientific review
-
Mark
A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.
(
- Contribution to journal › Article
-
Mark
NGF rescues hippocampal cholinergic neuronal markers, restores neurogenesis, and improves the spatial working memory in a mouse model of Huntington's Disease
(
- Contribution to journal › Article
- 2012
-
Mark
Neuronal Properties, In Vivo Effects, and Pathology of a Huntington's Disease Patient-Derived Induced Pluripotent Stem Cells
(
- Contribution to journal › Article
-
Mark
Can Parkinson's disease pathology be propagated from one neuron to another?
(
- Contribution to journal › Article
-
Mark
Neuregulin-1 receptor tyrosine kinase ErbB4 is upregulated in midbrain dopaminergic neurons in Parkinson disease
(
- Contribution to journal › Article
-
Mark
Late onset vascular dysfunction in the R6/1 model of Huntington's disease.
2012) In European Journal of Pharmacology(
- Contribution to journal › Article
-
Mark
Neuropathology in transplants in Parkinson's disease: Implications for disease pathogenesis and the future of cell therapy.
(
- Contribution to journal › Article
- 2011
-
Mark
Identification of molecules derived from human fibroblast feeder cells that support the proliferation of human embryonic stem cells.
(
- Contribution to journal › Article
-
Mark
alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
(
- Contribution to journal › Article
-
Mark
Neurogenesis In The R6/2 Mouse Model Of Huntington'S Disease Is Impaired At The Level Of Neurod1
(
- Contribution to journal › Article
-
Mark
Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Stage-Specific Modulation of Cortical Neuronal Development by Mmu-miR-134
(
- Contribution to journal › Article
-
Mark
Systemic administration of Neuregulin-1ß(1) protects dopaminergic neurons in a mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease
(
- Contribution to journal › Article
-
Mark
Membrane Interaction of α-Synuclein in Different Aggregation States
(
- Contribution to journal › Article
-
Mark
The executioners sing a new song: killer caspases activate microglia
(
- Contribution to journal › Scientific review
-
Mark
A deadly spread: cellular mechanisms of α-synuclein transfer.
(
- Contribution to journal › Article
-
Mark
Journal of Parkinson's Disease Introduction
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Caspase signalling controls microglia activation and neurotoxicity.
(
- Contribution to journal › Article
-
Mark
Can alpha-synuclein be targeted in novel therapies for Parkinson's disease?
(
- Contribution to journal › Article
-
Mark
IGF-1 protects against diabetic features in an in vivo model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice.
(
- Contribution to journal › Article
-
Mark
Reduced neurogenesis in the rat hippocampus following high fructose consumption.
(
- Contribution to journal › Article
- 2010
-
Mark
Nitric Oxide Stimulates the Proliferation of Neural Stem Cells Bypassing the Epidermal Growth Factor Receptor
(
- Contribution to journal › Article
-
Mark
Foxa2 and Nurr1 Synergistically Yield A9 Nigral Dopamine Neurons Exhibiting Improved Differentiation, Function, and Cell Survival
(
- Contribution to journal › Article
-
Mark
Neural grafting in Parkinson's disease: problems and possibilities
(
- Contribution to journal › Scientific review
-
Mark
Characterization of Lewy Body Pathology in 12-and 16-Year Old Intrastriatal Mesencephalic Grafts Surviving in a Patient with Parkinson's Disease
(
- Contribution to journal › Published meeting abstract
-
Mark
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Does A "Prion-Like" Mechanism Contribute to the Spreading of Neuropathology in Parkinson's Disease?
(
- Contribution to journal › Published meeting abstract
-
Mark
Brain injury activates microglia that induce neural stem cell proliferation ex vivo and promote differentiation of neurosphere-derived cells into neurons and oligodendrocytes
(
- Contribution to journal › Article
-
Mark
Prion-like transmission of protein aggregates in neurodegenerative diseases.
(
- Contribution to journal › Scientific review
-
Mark
A simple method for large-scale generation of dopamine neurons from human embryonic stem cells.
(
- Contribution to journal › Article
-
Mark
Cell transplantation in Parkinson's disease: problems and perspectives.
(
- Contribution to journal › Article
-
Mark
Are synucleinopathies prion-like disorders?
(
- Contribution to journal › Article
-
Mark
GABAergic Differentiation Induced by Mash1 Is Compromised by the bHLH Proteins Neurogenin2, NeuroD1, and NeuroD2.
(
- Contribution to journal › Article
- 2009
-
Mark
BRAIN INJURY ACTIVATES MICROGLIA THAT INDUCE NEURAL STEM CELL PROLIFERATION AND PROMOTE DIFFERENTIATION OF NEUROSPHERE-DERIVED CELLS INTO NEURONS AND TO OLIGODENDROCYTES
(
- Contribution to journal › Published meeting abstract
-
Mark
Propagation of host disease to grafted neurons: Accumulating evidence
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment
(
- Contribution to journal › Article
-
Mark
Lewy body pathology in long-term fetal nigral transplants: is Parkinson's disease transmitted from one neural system to another?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.
(
- Contribution to journal › Article
-
Mark
Absence of striatal newborn neurons with mature phenotype following defined striatal and cortical excitotoxic brain injuries.
(
- Contribution to journal › Article
-
Mark
Neurogenin2 directs granule neuroblast production and amplification while NeuroD1 specifies neuronal fate during hippocampal neurogenesis.
(
- Contribution to journal › Article
-
Mark
Beyond the brain: widespread pathology in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Involvement of Ngn2, Tbr and NeuroD proteins during postnatal olfactory bulb neurogenesis.
(
- Contribution to journal › Article
-
Mark
Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats.
(
- Contribution to journal › Article
-
Mark
Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
(
- Contribution to journal › Article
- 2008
-
Mark
Weight loss in Huntington's disease is related to the number of CAG repeats
2008) EHDN Annual Meeting In Journal of Neurology, Neurosurgery and Psychiatry 79(Supplement 1). p.17-17(
- Contribution to journal › Published meeting abstract
-
Mark
Protein-protein interactions in poly-Q disease model
2008) EHDN Annual Meeting In Journal of Neurology, Neurosurgery and Psychiatry 79(Supplement 1). p.1-1(
- Contribution to journal › Published meeting abstract
-
Mark
Increased metabolism in the R6/2 mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy
(
- Contribution to journal › Article
-
Mark
The effect of alpha-synuclein knockdown on MPP plus toxicity in models of human neurons
(
- Contribution to journal › Article
-
Mark
Increased thirst and drinking in Huntington's disease and the R6/2 mouse
(
- Contribution to journal › Article
-
Mark
From bench to bed: the potential of stem cells for the treatment of Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Weight loss in Huntington disease increases with higher CAG repeat number
(
- Contribution to journal › Article
-
Mark
Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus
(
- Contribution to journal › Article
-
Mark
Mutant huntingtin can paradoxically protect neurons from death
(
- Contribution to journal › Scientific review
-
Mark
Future Cell- and Gene-Based Therapies for Parkinson's Disease
2008) p.145-156(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Research in motion: the enigma of Parkinson's disease pathology spread.
(
- Contribution to journal › Scientific review
-
Mark
Islet beta-cell area and hormone expression are unaltered in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Critical issues of clinical human embryonic stem cell therapy for brain repair.
(
- Contribution to journal › Article
-
Mark
Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Emerging restorative treatments for Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Effects on differentiation of embryonic ventral midbrain progenitors by Lmx1a, MSX1, Ngn2, and Pitx3.
2008) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 28(14). p.3644-3656(
- Contribution to journal › Article
-
Mark
Growth factors and feeder cells promote differentiation of human embryonic stem cells into dopaminergic neurons: a novel role for fibroblast growth factor-20.
(
- Contribution to journal › Article
-
Mark
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.
(
- Contribution to journal › Article
- 2007
-
Mark
Tyrosine hydroxylase expression is unstable in a human immortalized mesencephalic cell line - Studies in vitro and after intracerebral grafting in vivo
(
- Contribution to journal › Article
-
Mark
Cocaine- and amphetamine-regulated transcript is increased in Huntington disease.
(
- Contribution to journal › Article
-
Mark
Reduced expression of PSA-NCAM in the hippocampus and piriform cortex of the R6/1 and R6/2 mouse models of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Midbrain expression of Delta-like 1 homologue is regulated by GDNF and is associated with dopaminergic differentiation.
(
- Contribution to journal › Article
-
Mark
Decreased VIP and VPAC(2) receptor expression in the biological clock of the R6/2 Huntington's disease mouse
(
- Contribution to journal › Article
-
Mark
Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Restorative cell therapy for Parkinson's disease: A quest for the perfect cell
(
- Contribution to journal › Scientific review
-
Mark
"NeuroStem Chip": a novel highly specialized tool to study neural differentiation pathways in human stem cells.
(
- Contribution to journal › Article
-
Mark
Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells.
(
- Contribution to journal › Article
-
Mark
Large stem cell grafts could lead to erroneous interpretations of behavioral results?
(
- Contribution to journal › Letter
-
Mark
Adult neurogenesis in neurodegenerative diseases
2007) p.445-445(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2006
-
Mark
Induction of dopaminergic neurons from growth factor expanded neural stem/progenitor cell cultures derived from human first trimester forebrain.
(
- Contribution to journal › Article
-
Mark
On the move to stimulate cell plasticity in the substantia nigra in Parkinson's disease.
(
- Contribution to journal › Letter
-
Mark
Cholinergic neuronal defect without cell loss in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Working memory training decreases hippocampal neurogenesis.
(
- Contribution to journal › Article
-
Mark
High-fat diet impairs hippocampal neurogenesis in male rats.
(
- Contribution to journal › Article
-
Mark
Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.
(
- Contribution to journal › Letter
-
Mark
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
(
- Contribution to journal › Scientific review
-
Mark
Enriched Environment Attenuates Cell Genesis in Subventricular Zone After Focal Ischemia in Mice and Decreases Migration of Newborn Cells to the Striatum.
(
- Contribution to journal › Article
-
Mark
Failure of transdifferentiation of adult hematopoietic stem cells into neurons.
(
- Contribution to journal › Article
-
Mark
Endothelial proliferation and increased blood-brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl-L-alanine-induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
Transplantation in Parkinson's disease: The future looks bright.
(
- Contribution to journal › Article
-
Mark
Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: Effect of in vitro differentiation on graft survival and teratoma formation
(
- Contribution to journal › Article
-
Mark
The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.
(
- Contribution to journal › Article
- 2005
-
Mark
Stromal cell-derived inducing activity does not promote dopaminergic differentiation, but enhances differentiation and proliferation of neural stem cell-derived astrocytes.
(
- Contribution to journal › Article
-
Mark
Lentiviral gene delivery of GDNF into the striatum of R6/2 Huntington mice fails to attenuate behavioral and neuropathological changes.
(
- Contribution to journal › Article
-
Mark
Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction.
(
- Contribution to journal › Article
-
Mark
Proteolysis of NR2B by calpain in the hippocampus of epileptic rats.
(
- Contribution to journal › Article
-
Mark
Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Evidence for dopaminergic re-innervation by embryonic allografts in an optimized rat model of the Parkinsonian variant of multiple system atrophy.
(
- Contribution to journal › Article
-
Mark
Orexin loss in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient {beta}-cell mass and exocytosis.
(
- Contribution to journal › Article
-
Mark
Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
(
- Contribution to journal › Article
-
Mark
Combining neuroprotective treatment of embryonic nigral donor tissue with mild hypothermia of the graft recipient.
(
- Contribution to journal › Article
-
Mark
Platelet-Derived Growth Factor (PDGF-BB) and Brain-Derived Neurotrophic Factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions.
(
- Contribution to journal › Article
-
Mark
The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.
(
- Contribution to journal › Article
-
Mark
Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor.
(
- Contribution to journal › Article
-
Mark
Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.
(
- Contribution to journal › Article
-
Mark
Stem cell-based therapy for Parkinson's disease.
(
- Contribution to journal › Scientific review
-
Mark
Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway
(
- Contribution to journal › Article
-
Mark
Synaptic dysfunction in Huntington's disease: a new perspective
(
- Contribution to journal › Scientific review
- 2004
-
Mark
Harnessing endogenous stem cells to treat neurodegenerative disorders of the basal ganglia.
(
- Contribution to journal › Article
-
Mark
Stem cell therapy for Parkinson's disease: where do we stand?
(
- Contribution to journal › Scientific review
-
Mark
Asialoerythropoetin is not effective in the R6/2 line of Huntington's disease mice
(
- Contribution to journal › Article
-
Mark
No evidence for new dopaminergic neurons in the adult mammalian substantia nigra.
(
- Contribution to journal › Article
- 2003
-
Mark
Ultrastructural characterization of dissociated embryonic ventral mesencephalic tissue treated with neuroprotectants.
(
- Contribution to journal › Article
-
Mark
Cyclosporin A and Bcl-2 do not inhibit quinolinic acid-induced striatal excitotoxicity in rodents
(
- Contribution to journal › Article
-
Mark
The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg
(
- Contribution to journal › Scientific review
-
Mark
Overexpression of heat shock protein 70 in R6/2 Huntington's disease mice has only modest effects on disease progression.
(
- Contribution to journal › Article
-
Mark
Fria radikaler och sjuka proteiner - bovarna bakom Parkinsons sjukdom?[Free radicals and ailing proteins - the culprits behind Parkinson’s disease?]
(
- Contribution to journal › Article
-
Mark
Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation.
(
- Contribution to journal › Article
-
Mark
Huntington's disease: a synaptopathy?
(
- Contribution to journal › Article
-
Mark
Grafting dopamine neurons in Parkinson's disease: do stem cells have a role in the future?
(
- Contribution to journal › Article
-
Mark
Neural transplantation for the treatment of Parkinson's disease
(
- Contribution to journal › Debate/Note/Editorial
- 2002
-
Mark
Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice.
(
- Contribution to journal › Article
-
Mark
Characterisation of cell damage and death in embryonic mesencephalic tissue: a study on ultrastructure, vital stains and protease activity.
(
- Contribution to journal › Article
-
Mark
GDNF treatment in Parkinson's disease: time for controlled clinical trials?
(
- Contribution to journal › Letter
-
Mark
Effects of antioxidant pretreatment on the survival of embryonic dopaminergic neurons in vitro and following grafting in an animal model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Funding embryonic stem-cell research: will commerce counteract collaboration?
(
- Contribution to journal › Letter
-
Mark
Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Comparison between survival of lazaroid-treated embryonic nigral neurons in cell suspensions, cultures and transplants.
(
- Contribution to journal › Article
-
Mark
Increased Sensitivity to N-Methyl-D-Aspartate Receptor-Mediated Excitotoxicity in a Mouse Model of Huntington's Disease.
(
- Contribution to journal › Article
-
Mark
Huntington's disease: the mystery unfolds?
(
- Contribution to journal › Scientific review
-
Mark
Stem cells: hype or hope?
(
- Contribution to journal › Scientific review
-
Mark
Dyskinesias following neural transplantation in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.
(
- Contribution to journal › Scientific review
-
Mark
Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease.
(
- Contribution to journal › Scientific review
-
Mark
Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line.
(
- Contribution to journal › Article
- 2001
-
Mark
Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene
(
- Contribution to journal › Article
-
Mark
Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration
(
- Contribution to journal › Article
-
Mark
Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine
(
- Contribution to journal › Article
-
Mark
Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice
(
- Contribution to journal › Article
-
Mark
The neurobiology of cell transplantation in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length
(
- Contribution to journal › Article
-
Mark
Brain-derived neurotrophic factor inhibits apoptosis and dopamine-induced free radical production in striatal neurons but does not prevent cell death
(
- Contribution to journal › Article
-
Mark
Huntingtons sjukdom - ännu ett galet protein?
(
- Contribution to journal › Article
-
Mark
Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease
(
- Contribution to journal › Article
- 2000
-
Mark
Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons
(
- Contribution to journal › Article
-
Mark
FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons
(
- Contribution to journal › Article
-
Mark
Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor
(
- Contribution to journal › Article
-
Mark
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts
(
- Contribution to journal › Article
-
Mark
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Improving the survival of grafted embryonic dopamine neurons in rodent models of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Improving the survival of grafted dopaminergic neurons: a review over current approaches
(
- Contribution to journal › Article
-
Mark
Intrastriatal ventral mesencephalic xenografts of porcine tissue in rats : immune responses and functional effects
(
- Contribution to journal › Article
-
Mark
Increased survival of embryonic nigral neurons when grafted to hypothermic rats
(
- Contribution to journal › Article
-
Mark
Oxidative stress, mitochondrial permeability transition and activation of caspases in calcium ionophore A23187-induced death of cultured striatal neurons
(
- Contribution to journal › Article
-
Mark
Caspase inhibition increases embryonic striatal graft survival
(
- Contribution to journal › Article
-
Mark
Pretreatment with MK-801 or the lazaroid U-83836E does not enhance striatal graft survival
(
- Contribution to journal › Article
- 1999
-
Mark
Flunarizine improves the survival of grafted dopaminergic neurons
(
- Contribution to journal › Letter
-
Mark
Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity
(
- Contribution to journal › Article
-
Mark
Sequential bilateral transplantation in Parkinson's disease: effects of the second graft
(
- Contribution to journal › Article
-
Mark
Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts
(
- Contribution to journal › Article
-
Mark
Caspase inhibition reduces apoptosis and increases survival of nigral transplants
(
- Contribution to journal › Article
-
Mark
Neuronal death in nigral grafts in the absence of poly (ADP-ribose) polymerase activation
(
- Contribution to journal › Article
-
Mark
Graft survival
(
- Contribution to journal › Letter
-
Mark
Differential effects of Bcl-2 overexpression on fibre outgrowth and survival of embryonic dopaminergic neurons in intracerebral transplants
(
- Contribution to journal › Article
-
Mark
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
(
- Contribution to journal › Article
-
Mark
Grafts of Embryonic Dopamine Neurons in Rodent Models of Parkinson's Disease
1999) p.299-299(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 1998
-
Mark
Quinolinic acid-induced inflammation in the striatum does not impair the survival of neural allografts in the rat
(
- Contribution to journal › Article
- 1997
-
Mark
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Tirilazad Mesylate improves survival of rat and human embryonic mesencephalic neurons in vitro
(
- Contribution to journal › Article
-
Mark
Rat intrastriatal neural allografts challenged with skin allografts at different time points
(
- Contribution to journal › Article
-
Mark
Addition of allogeneic spleen cells causes rejection of intrastriatal embryonic mesencephalic allografts in the rat
(
- Contribution to journal › Article
- 1996
-
Mark
Fetal neocortical grafts placed in brain infarcts do not improve paw-reaching deficits in adult spontaneously hypertensive rats
(
- Contribution to journal › Article
-
Mark
DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Antioxidant treatment protects striatal neurons against excitotoxic insults
(
- Contribution to journal › Article
-
Mark
Methylprednisolone prevents rejection of intrastriatal grafts of xenogeneic embryonic neural tissue in adult rats
(
- Contribution to journal › Article
- 1995
-
Mark
Neocortical grafts placed in the infarcted brain of adult rats: few or no efferent fibers grow from transplant to host
(
- Contribution to journal › Article
-
Mark
Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Immune reactions following systemic immunization prior or subsequent to intrastriatal transplantation of allogeneic mesencephalic tissue in adult rats
(
- Contribution to journal › Article
-
Mark
Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats
(
- Contribution to journal › Article
- 1994
-
Mark
Survival of fetal neocortical grafts implanted in brain infarcts of adult rats: the influence of postlesion time and age of donor tissue
(
- Contribution to journal › Article
-
Mark
Lazaroids improve the survival of grafted rat embryonic dopamine neurons
1994) In Proceedings of the National Academy of Sciences of the United States of America 91(26). p.12-12408(
- Contribution to journal › Article
-
Mark
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease
(
- Contribution to journal › Article
- 1993
-
Mark
Functional integration of cortical grafts placed in brain infarcts of rats
(
- Contribution to journal › Article
-
Mark
Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture
(
- Contribution to journal › Article
-
Mark
Paw-reaching, sensorimotor, and rotational behavior after brain infarction in rats
(
- Contribution to journal › Article
-
Mark
Sequential intrastriatal grafting of allogeneic embryonic dopamine-rich neuronal tissue in adult rats : will the second graft be rejected?
(
- Contribution to journal › Article
-
Mark
Sequential intracerebral transplantation of allogeneic and syngeneic fetal dopamine-rich neuronal tissue in adult rats : will the first graft be rejected?
(
- Contribution to journal › Article
-
Mark
Fifteen months' follow-up on bilateral embryonic mesencephalic grafts in two cases of severe MPTP-induced parkinsonism
(
- Contribution to journal › Article
- 1992
-
Mark
Fetal neocortical grafts implanted in adult hypertensive rats with cortical infarcts following a middle cerebral artery occlusion: ingrowth of afferent fibers from the host brain
(
- Contribution to journal › Article
-
Mark
Vascularization of fetal neocortical grafts implanted in brain infarcts in spontaneously hypertensive rats
(
- Contribution to journal › Article
-
Mark
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
(
- Contribution to journal › Article
-
Mark
Transplantation of fetal dopamine neurons in Parkinson's disease : PET [18F]6-L-fluorodopa studies in two patients with putaminal implants
(
- Contribution to journal › Article
-
Mark
Transplantation of fetal dopamine neurons in Parkinson's disease : one-year clinical and neurophysiological observations in two patients with putaminal implants
(
- Contribution to journal › Article
- 1991
-
Mark
Transplanted allogeneic fetal dopamine neurons survive and improve motor function in idiopathic Parkinson's disease
(
- Contribution to journal › Article
- 1990
-
Mark
Chapter 83 Neural transplantation in Parkinson's disease : the Swedish experience
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
In reply : Fetal brain grafts and Parkinson's disease
(
- Contribution to journal › Letter
-
Mark
Nya lovande resultat med transplantation av nervceller till hjärnan vid Parkinsons sjukdom
(
- Contribution to journal › Article
-
Mark
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
The Importance of Graft Placement and Task Complexity for Transplant-Induced Recovery of Simple and Complex Sensorimotor Deficits in Dopamine Denervated Rats
(
- Contribution to journal › Article
-
Mark
Synaptic connections formed by grafts of different types of cholinergic neurons in the host hippocampus
(
- Contribution to journal › Article
-
Mark
Amelioration of spatial memory impairment by intrahippocampal grafts of mixed septal and raphe tissue in rats with combined cholinergic and serotonergic denervation of the forebrain
(
- Contribution to journal › Article
- 1989
-
Mark
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up
(
- Contribution to journal › Article
-
Mark
Survival and immunogenicity of dissociated allogeneic fetal neural dopamine-rich grafts when implanted into the brains of adult mice
(
- Contribution to journal › Article
-
Mark
Intracerebral xenografts of dopamine neurons : the role of immunosuppression and the blood-brain barrier
(
- Contribution to journal › Article
- 1988
-
Mark
Fetal dopamine-rich mesencephalic grafts in Parkinson's disease
(
- Contribution to journal › Letter
-
Mark
Immunological aspects of grafting in the mammalian central nervous system. : A review and speculative synthesis
(
- Contribution to journal › Scientific review
-
Mark
Human fetal basal forebrain neurons grafted to the denervated rat hippocampus produce an organotypic cholinergic reinnervation pattern
(
- Contribution to journal › Article
-
Mark
Human fetal dopamine neurons grafted in a rat model of Parkinson's disease : immunological aspects, spontaneous and drug-induced behaviour, and dopamine release
(
- Contribution to journal › Article
-
Mark
Immunological aspects of neural grafting in the mammalian central nervous system
(
- Contribution to journal › Article
-
Mark
Can human fetal dopamine neuron grafts provide a therapy for Parkinson's disease?
(
- Contribution to journal › Scientific review
-
Mark
Comparison of growth and reinnervation properties of cholinergic neurons from different brain regions grafted to the hippocampus
(
- Contribution to journal › Article
-
Mark
Human fetal dopamine neurons grafted in a rat model of Parkinson's disease : ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry
(
- Contribution to journal › Article
- 1987
-
Mark
Dopamine neurons grafted unilaterally to the nucleus accumbens affect drug-induced circling and locomotion
(
- Contribution to journal › Article
-
Mark
Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease
(
- Contribution to journal › Article
- 1986
-
Mark
Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease
(
- Contribution to journal › Article
- 1985
-
Mark
Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons
(
- Contribution to journal › Article